Bay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials Post author:Sam Post published:February 7, 2018 Post category:BioPharma Rani said the latest funding round brings its coffers a total of $142M. Source: BioSpace You Might Also Like Ovid Release: Company Names M.D., To Scientific Advisory Board January 19, 2017 Mass Layoffs Hit Ariad Employees After Takeda's $5.2 Billion Buyout Deal March 29, 2017 On a Roll: Sage Shows Off Early-Stage Insomnia Data January 30, 2018
